ZFirst

Tech & Features: Quantum Dot Immunofluorescence (QD-FIA) provides high low-concentration sensitivity, anti-light quenching stability, and specialized diluent to release bound VB12.
Target Scenarios: Elderly, pregnant populations, vegetarians, and clinical units.
Usage Effect: Delivers accurate quantitative results in 15–20 minutes for early diagnosis of anemia and neurological assessment.

Tech & Features: Quantum Dot Immunofluorescence (QD-FIA) provides ultra-sensitivity, strong anti-interference, and wide sample compatibility (serum, plasma, whole blood).
Target Scenarios: Emergency departments, chest pain centers, and small laboratories.
Usage Effect: Delivers laboratory-grade quantitative results in 10–15 minutes for rapid heart failure diagnosis and cardiac risk screening.

Certifications: National Medical Device Certificate (Lu Mechun Zhun 20222400188), ISO 13485.
Tech & Material: Quantum Dot Immunofluorescence (QD-FIA) with narrow emission for strong anti-interference.
Target Users & Applications: Primary medical institutions screening H-type hypertension, stroke risk, and pregnancy risks.

Technical Advantage: Quantum Dot fluorescence technology with high sensitivity and CV < 10% repeatability.
Material & Craftsmanship: High-brightness nanomaterials with strong anti-interference performance.
Application & Target Users: Pediatrics, gynecology/obstetrics, clinics, and community centers.

Technical Advantage: Quantum Dot fluorescence technology with an optimized dedicated sample diluent.
Material & Craftsmanship: Stable nanomaterials featuring narrow emission and strong anti-interference properties.
Application & Target Users: Clinical departments, laboratories, and perinatal care.

Technical Advantage: Quantum Dot fluorescence technology with CV < 10% high stability.
Material & Craftsmanship: Advanced nanomaterials with strong anti-interference performance.
Application & Target Users: Obstetrics/gynecology clinics, maternity hospitals, and labs.

Technical Advantage: Quantum Dot fluorescence technology with CV < 10% high stability.
Material & Craftsmanship: Advanced nanomaterials with strong anti-fluorescence quenching.
Application & Target Users: Emergency, ICU, operating rooms, and cardiology departments.

Technical Advantage: Quantum Dot fluorescence technology with 3-in-1 combo testing (cTnI/CK-MB/Myo).
Application & Target Users: Emergency departments, ICUs, and Chest Pain Centers.
Effectiveness: Eliminates single-item blind spots and yields accurate quantitative reports in 10–15 minutes.

Tech & Material: Advanced Quantum Dot technology with anti-bleaching nano-fluorescent material for superior sensitivity.
Accuracy & Speed: Pretreatment breaks protein bonds for precise, fully quantitative results in 10–15 mins.
Scenarios: Pediatrics, Elderly, Pregnant women (Osteoporosis, Rickets, Immunity).